Alimera Closes Series B

Alimera Sciences Inc., a San Diego-based ophthalmic pharmaceutical company, has completed the $15.9 million second-tranche of its Series B round. The initial $15.9 million tranche was called down in November 2005, with backers on both deals including BA Venture Partners, Domain Associates, Intersouth Partners, Polaris Venture Partners and Venrock Associates.